People are taking an unapproved weight-loss drug. AI found something surprising
An experimental weight-loss drug that has not yet received regulatory approval is already attracting users willing to obtain unapproved versions online. Now, scientists are using artificial intelligence to investigate their experiences, uncovering unexpected symptom reports that differ from those documented in clinical trials. The drug, retatrutide, belongs to a new generation of GLP-1 medications designed










